Abivax receives $920 million in cash to prepare for US launch: CEO

AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…

Lawmakers target power of health insurance giants

After years of unbridled expansion in nearly every corner of the health care system, the largest insurance conglomerates are facing…